---
title: "Transtek: The controlling shareholder will not reduce its holdings in the company this year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/234977911.md"
description: "Transtek stated on the interactive platform that the share reduction plan disclosed by the company's controlling shareholder and actual controller, Pan Weichao, on January 7, 2025, has been completed, and Pan Weichao will not reduce his holdings in the company again this year"
datetime: "2025-04-08T09:21:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/234977911.md)
  - [en](https://longbridge.com/en/news/234977911.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/234977911.md)
generator: "portal-rs"
---

# Transtek: The controlling shareholder will not reduce its holdings in the company this year

On April 8th, Jin10 Data reported that Transtek stated on the interactive platform that the share reduction plan disclosed by the company's controlling shareholder and actual controller, Pan Weichao, on January 7, 2025, has been completed, and Pan Weichao will not reduce his holdings in the company again this year

### Related Stocks

- [300562.CN](https://longbridge.com/en/quote/300562.CN.md)

## Related News & Research

- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [08:48 ETLanguageLine TranslateExpress Now Available in the Epic Toolbox](https://longbridge.com/en/news/296230987.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**